Now showing items 1-3 of 3

    • Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study 

      Chao, Samuel; Ying, Jay; Liew, Gailina; Marshall, Wayne; Liew, Choong-Chin; Burakoff, Robert (BioMed Central, 2013)
      Background: Colonoscopy is widely regarded to be the gold standard for colorectal cancer (CRC) detection. Recent studies, however, suggest that the effectiveness of colonoscopy is mostly confined to tumors on the left side ...
    • Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study 

      Lee, Scott D.; Rubin, David T.; Sandborn, William J.; Randall, Charles; Younes, Ziad; Schreiber, Stefan; Schwartz, David A.; Burakoff, Robert; Binion, David; Dassopoulos, Themos; Arsenescu, Razvan; Gutierrez, Alexandra; Scherl, Ellen; Kayhan, Cem; Hasan, Iram; Kosutic, Gordana; Spearman, Marshall; Sen, David; Coarse, Jason; Hanauer, Stephen (Lippincott Williams & Wilkins, 2016)
      Background: Patients with Crohn's disease in whom tumor necrosis factor antagonist therapy fails have limited treatment options, and the benefit of reintroducing the same therapy remains unclear. Here, we report results ...
    • The Role of Mesalamine in the Treatment of Ulcerative Colitis 

      Karagozian, Raffi; Burakoff, Robert (Dove Medical Press, 2007)
      Ulcerative colitis (UC) is a chronic inflammatory condition of unclear etiology affecting the large bowel, most commonly the rectum and extending proximally in a continuous fashion. The overall principle in the pathophysiolgy ...